Luca Issy
Analyst
RBC
Equibles does not estimate personal net worth.
About Luca Issy
Luca Issy is recorded as Analyst at RBC. Luca Issy has spoken on 3 earnings calls across 2 companies, most recently for Arrowhead Pharmaceuticals, Inc. on November 12, 2026. Those appearances were for Arrowhead Pharmaceuticals, Inc. (ARWR) and BridgeBio Pharma, Inc. (BBIO). The companies whose calls Luca Issy spoke on are classified in the Healthcare sector.
Luca Issy on recent calls
“And coming back to the April Seafood Lounge, Redempo, both you and Ionis have described having another competitor in the market as a tail wing. And recently, we learned that the Quick Start program that IONIS has adopted as essentially a bridge program before patients get covered.”
“Maybe on achondroplasia, you know, obviously Bob Moran last week mentioned that 100 patients have switched from VUGZOGO to UBUL or less than 10% of all the VUGZOGO patients, you know, they're obviously arguing at 10% such a low number to suggest that the market is very sticky and the patients are loyal to VUGZOGO.”
“Again, you're not commenting on whether there is or there's not a trend in terms of, like, increasing over fast. Again, rightly so, given that, you know, the data's still in Barco at ESP.”
Affiliation history
-
RBC
Analyst
Transcript header (unverified)
Current